Physician profile
Valerie E Tuck
NPI 1154538874
$607.97
in general payments reported to CMS, 2019-2025
8 companies · $98.74 in 2025
The $98.74 reported for 2025 was more than what 83% of Perinatal (Nurse Practitioner) providers received nationally (typical 2025 total: $29.14).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $140 · 2023: $274 · 2024: $95.66 · 2025: $98.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $468.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $468.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $267.12 | 2021-2023 | |
| Daiichi Sankyo INC. | $127.28 | 2021 | |
| Vanda Pharmaceuticals INC. | $98.74 | 2025 | Fanapt |
| Astellas Pharma US INC | $38.36 | 2024 | Veozah |
| Exeltis, USA INC. | $22.71 | 2024 | Slynd |
| Coopersurgical, INC. | $19.17 | 2023 | Paragard T 380a |
| Sage Therapeutics, LLC | $18.41 | 2024 | |
| Evofem Biosciences, INC. | $16.18 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Valerie Tuck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.